Anthony Semesi

686 Bay Street
Toronto, ON M5G0A4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activity.

A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activity.

Journal: Nature communications

Published: June 22, 2025

Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort.

Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort.

Journal: Microbiology spectrum

Published: February 19, 2025

Structural elucidation of full-length Pfs48/45 in complex with potent monoclonal antibodies isolated from a naturally exposed individual.

Structural elucidation of full-length Pfs48/45 in complex with potent monoclonal antibodies isolated from a naturally exposed individual.

Journal: Nature structural & molecular biology

Published: November 13, 2023

Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.

Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.

Journal: Immunity

Published: August 16, 2022

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes.

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes.

Journal: Immunity

Published: August 15, 2022

Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses.

Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses.

Journal: Immunity

Published: May 12, 2022

Engineering pan-HIV-1 neutralization potency through multispecific antibody avidity.

Engineering pan-HIV-1 neutralization potency through multispecific antibody avidity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 15, 2021

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers.

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers.

Journal: Nature communications

Published: January 13, 2021

Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies.

Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies.

Journal: Nature communications

Published: June 08, 2020

Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.

Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.

Journal: Nature communications

Published: June 04, 2018

Solution-state NMR structure of the putative morphogene protein BolA (PFE0790c) from Plasmodium falciparum.

Solution-state NMR structure of the putative morphogene protein BolA (PFE0790c) from Plasmodium falciparum.

Journal: Acta crystallographica. Section F, Structural biology communications

Published: November 18, 2014

Screening proteins for NMR suitability.

Screening proteins for NMR suitability.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 05, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026